Zynex (ZYXI) Stock Price

Zynex Price

NASDAQ·CLOSED
0.06
​
Market closed

Over the last 19 years Zynex grew revenue by 26.4% annually, reaching 192.35 M USD. Earnings per share have grown at 17.1% per year over the last 19 years. For Zynex, the net margin of 1.6% is down versus 11.3% a few years ago. At today's price the dividend yield works out to roughly 1.67%. The payout ratio is around 0% of earnings. The dividend has grown at 9.3% per year over the past 4 years.

Zynex stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zynex business model & stock analysis

Zynex Inc is an American company that manufactures and distributes medical devices and accessories. The company was founded in 1996 and is headquartered in Englewood, Colorado. In recent years, it has become a major player in the pain therapy market. The history of Zynex began with the development of a neurotherapeutic system called NeuroMove, which aimed to restore mobility in patients with paralysis after strokes or other neurological disorders. The company uses proprietary technology to provide safe and effective electrotherapeutic stimulation, which helps trigger muscle contractions and improve mobility. Over the years, the company has specialized in the development and sale of medical devices for pain therapy and rehabilitation. Zynex's products can be used in various areas, including electrostimulation, TENS and EMS therapy, home diagnostics, as well as blood pressure and oxygen measurement. Zynex offers devices specifically for pain therapy. These devices are used by many doctors and physiotherapists to support patients in their healing process. The company's flagship product is the Nexus D-11 EMS and TENS device, which is capable of conducting multiple pain treatments simultaneously. Another important device from Zynex is the InWave system, which applies FDA-approved electromagnetic wave therapy. The therapy is used for both acute and chronic pain and aims to promote the body's natural healing processes to relieve pain. Zynex also manufactures home diagnostic devices such as the blood sugar monitor and pulse oximeter, which can be regularly used by patients at home to monitor their well-being. These products help individuals develop an understanding of how their body responds to different treatments or environmental conditions. An important aspect of Zynex's business model is collaborating with healthcare customers. The company forms partnerships with medical facilities and practitioners to ensure that its products are effectively and safely utilized. These partnerships often include training programs to ensure that users of each device develop a basic understanding of how it works to ensure quality treatment. Zynex has also established a subsidiary called Zynex Medical Europe, which operates in European regions. The company is based in the Netherlands and is responsible for marketing and distributing Zynex's products in Europe. Overall, Zynex has established itself as a key player in the field of pain therapy and rehabilitation. Through its innovative technology and healthcare partnerships, the company is able to provide the best possible patient care.

Frequently asked questions about Zynex

Zynex Inc's business model revolves around developing, manufacturing, and marketing non-invasive medical devices and accessories. The company specializes in electrotherapy products that aid in pain management, rehabilitation, and physical therapy. Zynex Inc primarily focuses on three key business segments: electrotherapy, neurological diagnostics, and patient monitoring. With a commitment to innovation and quality, Zynex Inc serves healthcare professionals, patients, and medical institutions with its advanced medical technologies. Through this business model, Zynex Inc aims to improve patient outcomes, enhance quality of life, and contribute to the overall advancement of the medical industry.

Zynex Inc is primarily active in the medical device industry.

The main competitors of Zynex Inc in the market include companies such as Medtronic, Abbott Laboratories, and Neurometrix. These companies also specialize in medical devices and technology, providing similar products and services within the healthcare industry. Zynex Inc competes with these companies to capture market share and meet the needs of healthcare professionals and patients.

Zynex Inc is a reputable company with a rich history and background. Founded in 1996, Zynex has consistently grown and established itself as a leader in the medical technology industry. Specializing in electrotherapy devices, the company offers innovative solutions for pain management and rehabilitation. Zynex has successfully developed and commercialized numerous products that have helped improve the lives of patients worldwide. Their commitment to research and development, along with their dedication to customer satisfaction, has garnered them a strong reputation in the market. With a focus on technological advancements and a mission to enhance patient care, Zynex Inc continues to thrive and make a significant impact in the medical device industry.

Zynex Inc, a leading medical technology company, has achieved several significant milestones. The company successfully introduced NeuroMove, its flagship neuro rehabilitation therapy device, which has revolutionized the industry. Zynex Inc also received FDA approval for their innovative Pain Management products, including NexWave and Infinity Plus, providing advanced pain relief solutions to patients. Furthermore, the company expanded its reach across the United States, establishing a strong presence in the healthcare market. Zynex Inc's consistent focus on research and development, coupled with its commitment to improving patient outcomes, has positioned them as a leading player in the medical technology sector.

Zynex Inc is primarily present in the United States of America.

Zynex Inc represents values of innovation, excellence, and patient-centric care in the medical technology industry. With a corporate philosophy focused on delivering high-quality medical devices and exceptional customer service, Zynex Inc strives to enhance the lives of patients through advanced medical solutions. The company is dedicated to continuously innovating and developing state-of-the-art products that improve healthcare outcomes and patient experiences. Zynex Inc's commitment to excellence has made it a trusted name in the industry, providing effective and reliable medical solutions.

8 analysts currently rate the Zynex stock: 6 recommend buying, 2 holding and 0 selling. For 2026, analysts expect Zynex to generate revenue of 101.20 M USD and earnings per share of -0.45 USD.

Converted at the current exchange rate, the Zynex share trades at 0.05 EUR (0.06 USD).

The Zynex share (ZYXI) is listed on 1 stock exchanges, including: NASDAQ (ZYXI).

Zynex Inc is a healthcare company based in the United States that specializes in the development and marketing of medical devices and therapy equipment. The company was founded in 1996 and is headquartered in Lone Tree, Colorado. Zynex offers a wide range of products and services for various medical areas. The core areas of Zynex are electrotherapy, pain therapy, orthopedics, and neurology. In these areas, the company develops and produces medical devices such as electronic pain therapy devices, electromyography-guided therapy systems, neurological therapy devices, and custom-fit orthotic systems. Zynex's electrotherapy devices are used for pain relief and muscle stimulation. The devices are easy to use and can be used at home. The range includes portable muscle stimulation devices that relieve joint, back, or neck pain, as well as transcutaneous electrical nerve stimulation (TENS) devices that enable non-invasive pain treatment. Zynex also offers electromyography-guided therapy systems that are used in the rehabilitation after injuries or surgeries. These systems are specifically tailored to the individual needs of the patient and help restore muscle strength and function. In the field of neurology, Zynex offers devices for the treatment of stroke patients, including direct current stimulation systems and electronic muscle stimulation devices. These devices help improve the motor skills of the patients. Zynex's custom-fit orthotic system is an individually tailored orthosis system that provides protection and support for injuries or conditions. The orthotic systems are made from high-quality materials and are tailored to the individual needs of the patient. In addition to developing and manufacturing medical devices, Zynex also offers medical services, such as conducting electromyography tests and providing patients with orthotic aids. Zynex aims to offer medical products that improve patients' quality of life and contribute to their recovery. The company works closely with medical professionals to develop and launch its products on the market. In summary, Zynex Inc is an innovative and versatile company that specializes in the development and marketing of medical devices and therapy equipment. The company offers its customers a wide range of products and services that are tailored to the individual needs of patients. With its high-quality and effective products, Zynex contributes to people leading better and pain-free lives.

The expected revenue of Zynex is 101.20 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Zynex is -14.59 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Zynex is currently -0.13. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Zynex stock.

The price-to-sales ratio (P/S) of Zynex is currently 0.02. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Zynex stock.

The Eulerpool Quality Score for Zynex is 4/10.

The ISIN of Zynex is US98986M1036. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Zynex is A0Q5XP. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Zynex is ZYXI. The ticker symbol is used to trade Zynex shares on the stock exchange.

Fair ValueTerminal
0.05 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
192,354.00 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website zynex.com
Currency
USD
Initial public offering
Nov 27, 2002
ISIN
US98986M1036
Cusip
98986M103
Sedol
2226042
Market capitalization
1.82 M USDMicro Cap
52-Week Range
PEG
-0.02
P/E ratio
P/Ee 2025
-0.05
P/Ee 2026
-0.13
P/Ee 2027
-0.16
P/Ee 2028
-0.23
P/Ee 2029
-0.49
P/S
P/Se
0.02
EV/EBIT
3.65
P/B Ratio
0.05
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
3.14 %
Last updated Nov 22, 2026, 7:23 AM

Zynex Ticker

NASDAQ · ZYXI

Zynex FIGI

ZYXI:US · BBG000BJBXZ2ZYXI:UA · BBG000BJBYC5ZYXI:UC · BBG000BJBYM4ZYXI:UN · BBG000BJBZ50ZYXI:UP · BBG000BJBZN0ZYXI:UB · BBG000BJC0T0ZYXI:UM · BBG000BJC1T8ZYXI:UX · BBG000BJC252ZYXI:UD · BBG000BJC4V9ZYXI:UW · BBG000BJC617ZYXI:UF · BBG000BJC6V4ZYXI:VY · BBG000BJC7Z8

All fundamentals and in-depth analysis of Zynex

Our stock analysis for Zynex stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Zynex. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.